CCT020312 Catalog No.:M20811-C is an orally bioavailable inhibitor

is an orally bioavailable inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity

At 10 μM concentration

Smiles: CC1N=CSC=1C1C=CC(=CC=1)[C@H](C)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CCCCCCCCCCBr)C(C)(C)C

4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects

CCT020312 Catalog No.:M20811-C is an orally bioavailable inhibitorCCT020312 is a selective EIF2AK3 PERK activator. CCT020312 elicits EIF2A phosphorylation in cells. Product information CAS Number: 324759 76 4 Molecular Weight: 650. 40 Formula: C31H30Br2N4O2 Chemical Name: 6 bromo 3 [5 (4 bromophenyl) 1 [3 (diethylamino)propanoyl] 4,5 dihydro 1H pyrazol 3 yl] 4 phenyl 1,2 dihydroquinolin 2 one Smiles: CCN(CCC(=O)N1N=C(CC1C1C=CC(Br)=CC=1)C1=C(C2C=C(Br)C=CC=2NC1=O)C1C=CC=CC=1)CC InChiKey: OAXDKXMGESZLKV UHFFFAOYSA N